INR Goals for Mechanical Heart Valves
For mechanical aortic valves without risk factors, target an INR of 2.5 (range 2.0-3.0); for mechanical mitral valves or aortic valves with risk factors, target an INR of 3.0 (range 2.5-3.5). 1
Mechanical Aortic Valve Replacement
Low-Risk Patients (No Additional Risk Factors)
- Target INR of 2.5 (range 2.0-3.0) for bileaflet or current-generation single tilting disc valves in the aortic position 1, 2
- This applies specifically to modern low-thrombogenic valves like St. Jude Medical bileaflet valves 3
- Add aspirin 75-100 mg daily to warfarin therapy 1
High-Risk Patients (With Additional Risk Factors)
- Target INR of 3.0 (range 2.5-3.5) for mechanical aortic valves when any of the following risk factors are present: 1
Important caveat: Recent evidence challenges the higher INR target for high-risk aortic valve patients. A 2021 study found that higher-intensity anticoagulation (INR goal 3.0) was associated with significantly increased bleeding (adjusted HR 2.52) without reducing thromboembolic events compared to standard-intensity (INR goal 2.5) 4. A 2018 meta-analysis similarly showed lower INR targets reduced bleeding by 50% (22% vs 40%) with no difference in thromboembolism 5. However, current ACC/AHA guidelines still recommend the higher target, and these should be followed until guidelines are updated 1.
Mechanical Mitral Valve Replacement
- Target INR of 3.0 (range 2.5-3.5) for ALL mechanical mitral valve replacements, regardless of risk factors 1, 2, 3
- This higher target applies because mitral position carries inherently higher thrombotic risk 3
- Add aspirin 75-100 mg daily to warfarin therapy 1
Management After Thromboembolic Events While on Therapeutic Anticoagulation
For Mechanical Aortic Valves
- Increase INR goal from 2.5 (range 2.0-3.0) to 3.0 (range 2.5-3.5) if stroke or systemic embolism occurs while INR is therapeutic 1
- Alternatively, add low-dose aspirin 75-100 mg daily if not already prescribed, after assessing bleeding risk 1
For Mechanical Mitral Valves
- Increase INR goal from 3.0 (range 2.5-3.5) to 4.0 (range 3.5-4.5) if stroke or systemic embolism occurs while INR is therapeutic 1
- Alternatively, add low-dose aspirin 75-100 mg daily if not already prescribed, after assessing bleeding risk 1
Critical Pitfalls and Contraindications
Avoid These Common Errors
- Never use direct oral anticoagulants (DOACs): Dabigatran is absolutely contraindicated in mechanical valve patients 1, and anti-Xa DOACs (rivaroxaban, apixaban, edoxaban) have not been assessed and are not recommended 1
- Specify a single INR target value rather than just a range—this reduces the likelihood of patients consistently running at the upper or lower boundary 1
- INR fluctuations increase complications: Patients should strive for consistent INR values within the target range, not just anywhere within the acceptable range 1
Monitoring and Compliance Challenges
- Patients with target INR 2.0-3.5 achieve therapeutic range 74.5% of the time, while those with target INR 3.0-4.5 achieve it only 44.5% of the time 6
- Anticoagulation clinics with dedicated pharmacists or nurses result in lower complication rates than standard care 1
- Patient self-monitoring with home INR devices is effective for motivated patients and may allow tighter control 7